Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Albertelli

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|August 16, 2019
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine NeoplasmsFederico Gatto, Federica Barbieri, Marica Arvigo, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2022
Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small BowelFederica Grillo, Manuela Albertelli, Pasqualino Malandrino, et al.
Endocrine|September 13, 2015
Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?Federica Grillo, Manuela Albertelli, Francesca Annunziata, et al.
Drug Discovery Today|November 1, 2013
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapiesFederica Barbieri, Manuela Albertelli, Federica Grillo, et al.
Neuroendocrinology|September 5, 2015
Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary TumorFederica Grillo, Manuela Albertelli, Maria Pia Brisigotti, et al.
Frontiers in Endocrinology|May 10, 2021
Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to AskManuela Albertelli, Federica Grillo, Fabio Lo Calzo, et al.
Hormones (Athens, Greece)|November 18, 2014
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiencyMara Boschetti, Massimo Casu, Sara Moretti, et al.
Reviews in Endocrine & Metabolic Disorders|April 14, 2021
"Present and future of immunotherapy in Neuroendocrine Tumors"Manuela Albertelli, Andrea Dotto, Federica Nista, et al.
Endocrine|July 5, 2020
Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxideFederica Sileo, Biagio Cangiano, Chiara Cacciatore, et al.
Endocrine|April 15, 2016
One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patientsMara Boschetti, Sergio Agosti, Valeria Albanese, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|August 16, 2019
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine NeoplasmsFederico Gatto, Federica Barbieri, Marica Arvigo, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2022
Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small BowelFederica Grillo, Manuela Albertelli, Pasqualino Malandrino, et al.
Endocrine|September 13, 2015
Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?Federica Grillo, Manuela Albertelli, Francesca Annunziata, et al.
Drug Discovery Today|November 1, 2013
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapiesFederica Barbieri, Manuela Albertelli, Federica Grillo, et al.
Neuroendocrinology|September 5, 2015
Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary TumorFederica Grillo, Manuela Albertelli, Maria Pia Brisigotti, et al.
Frontiers in Endocrinology|May 10, 2021
Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to AskManuela Albertelli, Federica Grillo, Fabio Lo Calzo, et al.
Hormones (Athens, Greece)|November 18, 2014
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiencyMara Boschetti, Massimo Casu, Sara Moretti, et al.
Reviews in Endocrine & Metabolic Disorders|April 14, 2021
"Present and future of immunotherapy in Neuroendocrine Tumors"Manuela Albertelli, Andrea Dotto, Federica Nista, et al.
Endocrine|July 5, 2020
Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxideFederica Sileo, Biagio Cangiano, Chiara Cacciatore, et al.
Endocrine|April 15, 2016
One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patientsMara Boschetti, Sergio Agosti, Valeria Albanese, et al.
Pageof 7